Metabolism
Innovations in diabetes and obesity
Aretaeus is invested in a promising pipeline of small-molecular agents for the treatment of Type I and Type II diabetes mellitus and obesity.

Metabolism
Aretaeus is invested in a promising pipeline of small-molecular agents for the treatment of Type I and Type II diabetes mellitus and obesity.
Men's Health
Aretaeus is actively exploring a number of innovative solutions for male genitourinary disorders.
Support services